These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 1116152)

  • 1. The effects of an antimetastatic agent, (plus or minus)-1,2-bis(3,5-dioxopiperazin-1-yl)propane (ICRF 159), on platelet behavior.
    Atherton A; Busfield D; Hellman K
    Cancer Res; 1975 Apr; 35(4):953-7. PubMed ID: 1116152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of (plus or minus)-1,2-bis(3,5-dioxopiperazin-1-yl)propane on tumor blood vessels and its relationship to the antimetastatic effect in the Lewis lung carcinoma.
    James SE; Salsbury AJ
    Cancer Res; 1974 Apr; 34(4):839-42. PubMed ID: 4814996
    [No Abstract]   [Full Text] [Related]  

  • 3. Histological analysis of the antimetastatic effect of (plus or minus)-1,2-bis(3,5-dioxopiperazin-1-yl)propane.
    Salsbury AJ; Burrage K; Hellmann K
    Cancer Res; 1974 Apr; 34(4):843-9. PubMed ID: 4814997
    [No Abstract]   [Full Text] [Related]  

  • 4. Selectivity of the antimetastatic and cytotoxic effects of 1-p-(3,3-dimethyl-1-triazeno)benzoic acid potassium salt (+/-)-1,2-di(3,5-dioxopiperazin-1-yl)propane, and cyclophosphamide in mice bearing Lewis lung carcinoma.
    Giraldi T; Sava G; Cuman R; Nisi C; Lassiani L
    Cancer Res; 1981 Jun; 41(6):2524-8. PubMed ID: 7237446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of the R3327MAT-Lu prostatic tumor by diethylstilbestrol and 1,2-bis(3,5-dioxopiperazin-1-yl)propane.
    Lazan DW; Heston WD; Kadmon D; Fair WR
    Cancer Res; 1982 Apr; 42(4):1390-4. PubMed ID: 7060012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the L isomer (+)-1,2-bis(3,5-dioxopiperazine-1-yl)propane on cell survival and cell cycle progression of cultured mammalian cells.
    Traganos F; Darzynkiewicz Z; Melamed MR
    Cancer Res; 1981 Nov; 41(11 Pt 1):4566-76. PubMed ID: 6171341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of AVS (1,2-bis(nicotinamido)propane) on platelet function and vascular endothelium.
    Mizukami M; Neichi T; Yamazaki T; Koide T; Noda Y; Matsushita H; Hata S; Nakano M
    Arzneimittelforschung; 1984; 34(7):764-8. PubMed ID: 6238600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of (+/-) 1,2-bis(3,5-dioxopiperazin-1-yl) propane (ICRF 159) on liver metastases from a hamster lymphoma.
    Atherton A
    Eur J Cancer (1965); 1975 Jun; 11(6):383-8. PubMed ID: 1174351
    [No Abstract]   [Full Text] [Related]  

  • 9. Hemostasis and mechanism of action of selective antimetastatic drugs in mice bearing Lewis lung carcinoma.
    Giraldi T; Sava G; Mitri E; Cherubino R
    Eur J Cancer Clin Oncol; 1984 Jul; 20(7):961-6. PubMed ID: 6540195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of etofylline clofibrate on experimental thrombosis and platelet function.
    Sim AK; Davies ME; McCraw AP; Metz G
    Arzneimittelforschung; 1980; 30(11b):2042-5. PubMed ID: 7194057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycoprotein Ibalpha inhibition and ADP receptor antagonists, but not aspirin, reduce platelet thrombus formation in flowing blood exposed to atherosclerotic plaques.
    Penz SM; Reininger AJ; Toth O; Deckmyn H; Brandl R; Siess W
    Thromb Haemost; 2007 Mar; 97(3):435-43. PubMed ID: 17334511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of experimental lung metastases by cultured B16 melanoma cells treated with (+/-)-1,2-bis(3,5-dioxopiperazin-1-y)propane (ICRF-159).
    Lazo JS; Ingber DE; Sartorelli AC
    Cancer Res; 1978 Aug; 38(8):2263-70. PubMed ID: 667822
    [No Abstract]   [Full Text] [Related]  

  • 13. Antithrombotic effects of the novel inhibitor of thrombin-induced offtelet aggregation and thrombus formation, 3-[2-[1,1':2',1"]-terphenyl-4'-yl)ethyl]phenoxyacetic acid.
    Miyamae T; Hashizume H; Ogawa T; Okayama T; Nukui E; Oshima K; Morikawa T; Hagiwara M
    Arzneimittelforschung; 1997 Jan; 47(1):13-8. PubMed ID: 9037437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bromelain proteases reduce human platelet aggregation in vitro, adhesion to bovine endothelial cells and thrombus formation in rat vessels in vivo.
    Metzig C; Grabowska E; Eckert K; Rehse K; Maurer HR
    In Vivo; 1999; 13(1):7-12. PubMed ID: 10218125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prenatal effects of the cancer chemotherapeutic drug ICRF 159 in mice, rats, and rabbits.
    Duke DI
    Teratology; 1975 Feb; 11(1):119-26. PubMed ID: 1138404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Scavenging of probimane on semiquinone free radical formation by doxorubicin in rat heart].
    Zhang Y; Zhang TM; Zhao BL; Han JK; Chen WC; Xin WJ
    Zhongguo Yao Li Xue Bao; 1991 Jan; 12(1):20-3. PubMed ID: 1950578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ICRF 159, (+/-) 1,2-di(3,5-dioxopiperazin-1-yl) propane NSC-129,943; razoxane.
    Bakowski MT
    Cancer Treat Rev; 1976 Jun; 3(2):95-107. PubMed ID: 821609
    [No Abstract]   [Full Text] [Related]  

  • 18. [Cytokinetic effects of 1,2-bis(4-isobutoxycarbonyloxymethyl-3,5- dioxopiperazin-1-yl) ethane (MST-16) on leukemia L1210 cells in mice].
    He H; Wang MY; Zhang TM
    Zhongguo Yao Li Xue Bao; 1988 Jul; 9(4):369-73. PubMed ID: 3195349
    [No Abstract]   [Full Text] [Related]  

  • 19. Synergistic activity of doxorubicin and the bisdioxopiperazine (+)-1,2-bis(3,5-dioxopiperazinyl-1-yl)propane (ICRF 187) against the murine sarcoma S180 cell line.
    Wadler S; Green MD; Muggia FM
    Cancer Res; 1986 Mar; 46(3):1176-81. PubMed ID: 3080237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of topoisomerase II by antitumor agents bis(2,6-dioxopiperazine) derivatives.
    Tanabe K; Ikegami Y; Ishida R; Andoh T
    Cancer Res; 1991 Sep; 51(18):4903-8. PubMed ID: 1654204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.